HRSA Refines HIV/AIDS Program Expense Tracking Forms
Published Date: 12/31/2025
Notice
Summary
HRSA is updating the Ryan White HIV/AIDS Program spending reports to better track how grant money is used by recipients. If you get funding from this program, you’ll need to keep reporting your expenses as usual, but HRSA wants your feedback on the changes by March 2, 2026. This helps make sure funds support important HIV care and prevention without adding extra hassle or cost.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
RWHAP Grantees Must Keep Reporting
If you receive Ryan White HIV/AIDS Program funding under Parts A, B, C, or D, or funding under the Ending the HIV Epidemic (EHE) initiative, you must continue to report financial data at the end of your grant budget period. HRSA proposes to extend the RWHAP Expenditures Reports (Part A, Part B, Part B Supplemental, Part C, Part D, and EHE Expenditures Reports).
Estimated Reporting Time: 2,530 Hours
HRSA estimates the total annual burden for these reports is 2,530 hours across 648 respondents. The breakdown is: Part A — 52 respondents × 2 hours = 104 hours; Part B — 54 respondents × 6 hours = 324 hours; Part B Supplemental — 33 respondents × 2 hours = 66 hours; Part C — 346 respondents × 4 hours = 1,384 hours; Part D — 116 respondents × 4 hours = 464 hours; EHE — 47 respondents × 4 hours = 188 hours.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16871, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Maternity and Obstetrics Management Strategies Program Data Collection, OMB No. 0915-0394-Revision
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
2026-16396, National Newborn Screening Stakeholder Workgroup
HRSA provides funding to support a national center for newborn screening systems known as the National Center for Newborn Screening Systems Excellence (NBS Excel). In fiscal year 2026, supplemental funding is being provided to NBS Excel to establish a national newborn screening stakeholder workgroup. This workgroup will be a pathway for conditions to be considered and recommended for inclusion in the Recommended Uniform Screening Panel (RUSP) and to discuss national- level issues related to newborn screening. Membership will include representatives from a wide range of newborn screening experts and stakeholders. The award recipient will convene the workgroup and develop findings, reports, and recommendations for HRSA's review and consideration. HRSA will then make recommendations to the Secretary of Health and Human Services, who has final decision-making authority on updates to the RUSP.
2026-16227, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Transforming Pediatrics for Early Childhood Program Performance Measures
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-16054, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Organ Procurement and Transplantation Network Board of Directors and Committee Member Applications and Forms
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
2026-15596, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; National Health Service Corps Scholar/Students to Service Travel Worksheet, OMB No. 0906-0087-Revision
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-15633, Notice Regarding 340B Rebate Model Pilot Program
The U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA), which administers the 340B Drug Pricing Program (340B Program), is issuing this Notice to announce the availability of a revised 340B Rebate Model Pilot Program (Pilot). The Pilot provides a rebate mechanism through which qualifying drug manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities. Consistent with HRSA's longstanding statutory authority, rebates will be used instead of upfront discounts. HRSA issued a Request for Information (RFI) \1\ to gather input from interested parties regarding the potential use of rebates to effectuate the ceiling price under the 340B Program, including the standards and procedures that should govern the approval of manufacturer rebate plans and the impacts on all stakeholders. After carefully considering all comments from interested parties and different policy alternatives, HRSA is announcing this Pilot, which will implement a rebate approach for a limited set of drugs, and which builds on established and successful rebate programs. ---------------------------------------------------------------------------
Previous / Next Documents
Previous: 2025-24088, Columbia Gulf Transmission, LLC; Notice of Request Under Blanket Authorization and Establishing Intervention and Protest Deadline
Columbia Gulf Transmission wants to replace a 2,620-foot section of its big pipeline crossing Casey Creek in Kentucky with a new 2,700-foot pipe to stop erosion damage. This $22 million project helps keep gas flowing safely and on time. If you care, you’ve got until a set deadline to speak up or join the conversation!
Next: 2025-24090, Combined Notice of Filings #1
The Federal Energy Regulatory Commission got a bunch of new filings from power companies about accounting changes, rate updates, and company approvals. These updates could affect how some companies handle money and operations, with deadlines for public comments coming up in early January 2026. If you’re involved in energy or just curious, now’s the time to check out these important moves shaping the power world!